Marth, C <br/><br/>
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.  [electronic resource] 

 -  British journal of cancer  1997 
 - 1328-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1997.556  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cisplatin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Female<br/>Genes, erbB-2<br/>HLA-DR Antigens--analysis<br/>Humans<br/>Interferon-gamma--pharmacology<br/>Ovarian Neoplasms--drug therapy<br/>Tumor Cells, Cultured